1. Fung, V, Kohlhardt, S, Vergani, P, Zardin, GJ, Williams, NR. Intraoperative prediction of the two axillary lymph node macrometastases threshold in patients with breast cancer using a one-step nucleic acid cytokeratin-19 amplification assay. Mol Clin Oncol. 2017;7:755-762. doi:10.3892/mco.2017.1404.
Google Scholar | Crossref | Medline2. Fleming, FJ. Factors affecting metastases to non-sentinel lymph nodes in breast cancer. J Clin Pathol. 2004;57:73-76. doi:10.1136/jcp.57.1.73.
Google Scholar | Crossref | Medline3. Bolster, MJ, Peer, PGM, Bult, P, et al. Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol. 2007;14:181-189. doi:10.1245/s10434-006-9065-1.
Google Scholar | Crossref | Medline4. Di Filippo, F, Di Filippo, S, Ferrari, AM, et al. Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: retrospective and validation phase. J Exp Clin Cancer Res. 2016;35:193. doi:10.1186/s13046-016-0460-6.
Google Scholar | Crossref | Medline5. Di Filippo, F, Giannarelli, D, Bouteille, C, et al. Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method. J Exp Clin Cancer Res. 2015;34:136. doi:10.1186/s13046-015-0246-2.
Google Scholar | Crossref | Medline6. Tsujimoto, M, Nakabayashi, K, Yoshidome, K, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res. 2007;13:4807-4816. doi:10.1158/1078-0432.CCR-06-2512.
Google Scholar | Crossref | Medline | ISI7. Veronesi, U, Paganelli, G, Viale, G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. JNCI J Natl Cancer Inst. 1999;91:368-373. doi:10.1093/jnci/91.4.368.
Google Scholar | Crossref8. Rahusen, FD, Pijpers, R, Van Diest, PJ, Bleichrodt, RP, Torrenga, H, Meijer, S. The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery. 2000;128:6-12. doi:10.1067/msy.2000.107229.
Google Scholar | Crossref | Medline9. Galimberti, V, Cole, BF, Zurrida, S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23tases (IBCSG 23crandomised controlled trial. Lancet Oncol. 2013;14:297-305. doi:10.1016/S1470-2045(13)70035-4.
Google Scholar | Crossref | Medline | ISI10. Fleissig, A, Fallowfield, LJ, Langridge, CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95:279-293. doi:10.1007/s10549-005-9025-7.
Google Scholar | Crossref | Medline | ISI11. Langer, I, Guller, U, Berclaz, G, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007;245:452-461. doi:10.1097/01.sla.0000245472.47748.ec.
Google Scholar | Crossref | Medline | ISI12. Reynolds, C, Mick, R, Donohue, JH, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol. 1999;17:1720-1726. doi:10.1200/JCO.1999.17.6.1720.
Google Scholar | Crossref | Medline | ISI13. van la Parra, RF, Peer, PG, Ernst, MF, Bosscha, K. Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN. Eur J Surg Oncol. 2011;37:290-299. doi:10.1016/j.ejso.2011.01.006.
Google Scholar | Crossref | Medline14. Mittendorf, E, Hunt, K, Boughey, J, et al. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg. 2012;255:109-115. doi:10.1097/SLA.0b013e318238f461.
Google Scholar | Crossref | Medline | ISI15. Hessman, CJ, Naik, AM, Kearney, NM, et al. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer. Arch Surg. 2011;146:1035-1040. doi:10.1001/archsurg.2011.201.
Google Scholar | Crossref | Medline16. The Bay Area SLN , Study Kohrt, HE, Olshen, RA, et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer. 2008;8:66. doi:10.1186/1471-2407-8-66.
Google Scholar | Crossref | Medline17. Peg, V, Espinosa-Bravo, M, Vieites, B, et al. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients. Breast Cancer Res Treat. 2013;139:87-93. doi:10.1007/s10549-013-2524-z.
Google Scholar | Crossref | Medline18. Espinosa-Bravo, M, Sansano, I, Pérez-Hoyos, S, et al. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay. Eur J Surg Oncol. 2013;39:766-773. doi:10.1016/j.ejso.2013.03.011.
Google Scholar | Crossref | Medline19. Sa-Nguanraksa, D, O-Charoenrat, E, Kulprom, A, et al. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand. Breast Cancer. 2019;26:471-477. doi:10.1007/s12282-019-00945-8.
Google Scholar | Crossref | Medline20. Rubio, IT, Espinosa-Bravo, M, Rodrigo, M, et al. Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients. Breast Cancer Res Treat. 2014;147:371-380. doi:10.1007/s10549-014-3108-2.
Google Scholar | Crossref | Medline21. Morigi, C. Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer. E cancer medical science. 2017;11:732. doi:10.3332/ecancer.2017.732.
Google Scholar | Crossref